Rheumatology

UA Startup ProNeurogen Advances New Therapies for Vascular Dementia, Announces Award of Patents for Intellectual Property

Tucson Ariz. – Today, billions of dollars are spent each year on health-care costs related to the treatment of patients with inflammation-related brain disorders such as vascular dementia, yet no FDA-approved therapies exist for for these conditions.

Pages

Subscribe to RSS - Rheumatology